Jean-Marc Lacorte Selected Research

C-Reactive Protein

9/2018	Wide-range CRP versus high-sensitivity CRP on Roche analyzers: focus on low-grade inflammation ranges and high-sensitivity cardiac troponin T levels.
1/2011	Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Marc Lacorte Research Topics

Disease

13	Obesity 12/2021 - 06/2007
11	Insulin Resistance 01/2020 - 12/2003
7	Neoplasms (Cancer) 01/2021 - 04/2002
6	Weight Loss (Weight Reduction) 01/2022 - 01/2005
4	COVID-19 01/2022 - 01/2021
4	Morbid Obesity 01/2021 - 05/2006
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2019
3	Hypertriglyceridemia 01/2020 - 05/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 05/2010
3	Colorectal Neoplasms (Colorectal Cancer) 12/2017 - 01/2003
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 06/2012
2	Inflammation (Inflammations) 09/2018 - 01/2011
2	Non-alcoholic Fatty Liver Disease 10/2017 - 07/2008
2	Hyperphagia (Overeating) 12/2016 - 02/2013
2	Breast Neoplasms (Breast Cancer) 03/2016 - 11/2014
2	Hyperlipidemias (Hyperlipidemia) 02/2016 - 07/2015
2	Overweight 01/2015 - 08/2005
2	Dyslipidemias (Dyslipidemia) 05/2010 - 08/2005
2	Colonic Neoplasms (Colon Cancer) 01/2003 - 04/2002
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Reinfection 01/2021
1	Glioma (Gliomas) 01/2021
1	Abdominal obesity metabolic syndrome 01/2020
1	Cardiomyopathies (Cardiomyopathy) 01/2020
1	Alcoholic Fatty Liver 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2019
1	Liver Abscess 02/2019
1	Infections 02/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 02/2019
1	Cystic Fibrosis (Mucoviscidosis) 02/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Vascular Calcification 01/2019
1	Peripheral Arterial Occlusive Disease 1 01/2019
1	Hypoglycemia (Reactive Hypoglycemia) 01/2018
1	Body Weight (Weight, Body) 10/2017
1	Fatigue 01/2017
1	Vitamin D Deficiency 12/2016
1	Craniopharyngioma (Craniopharyngiomas) 05/2016
1	Hyperinsulinism (Hyperinsulinemia) 05/2016

Drug/Important Bio-Agent (IBA)

11	LeptinIBA 01/2021 - 01/2005
9	AdiponectinIBA 01/2020 - 12/2003
6	Triglycerides (Triacylglycerol)IBA 01/2020 - 05/2010
6	Insulin (Novolin)FDA Link 01/2015 - 08/2005
4	Interleukin-6 (Interleukin 6)IBA 12/2021 - 01/2005
4	Hormones (Hormone)IBA 01/2020 - 09/2013
3	Biological ProductsIBA 02/2019 - 12/2017
3	Leptin ReceptorsIBA 01/2019 - 02/2013
3	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 10/2017 - 05/2006
3	AdipokinesIBA 12/2016 - 08/2005
3	GhrelinIBA 12/2016 - 01/2015
3	Lipoproteins (Lipoprotein)IBA 06/2012 - 01/2010
2	AntibodiesIBA 01/2021 - 10/2016
2	CytokinesIBA 01/2021 - 01/2010
2	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2021 - 10/2017
2	CholesterolIBA 01/2020 - 02/2016
2	CarbohydratesIBA 02/2019 - 05/2010
2	C-Reactive ProteinIBA 09/2018 - 01/2011
2	Peptides (Polypeptides)IBA 01/2018 - 10/2017
2	Biomarkers (Surrogate Marker)IBA 01/2013 - 01/2011
2	LipidsIBA 06/2012 - 01/2010
2	Glucose (Dextrose)FDA LinkGeneric 05/2010 - 01/2010
1	AldosteroneIBA 01/2022
1	ReninIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2021
1	MelanocortinsIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	VaccinesIBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	LigandsIBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	AntigensIBA 02/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2019
1	Tumor Biomarkers (Tumor Markers)IBA 02/2019
1	Troponin T (Troponin T1)IBA 09/2018
1	GlicentinIBA 01/2018
1	Proglucagon (Glucagon Precursors)IBA 01/2018
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 12/2017
1	Protons (Proton)IBA 10/2017
1	setmelanotideIBA 10/2017
1	25-hydroxyvitamin DIBA 12/2016
1	hydroxide ionIBA 12/2016
1	Vitamin D FDA LinkGeneric 12/2016
1	Cetuximab (Erbitux)FDA Link 10/2016
1	Panitumumab (Vectibix)FDA Link 10/2016
1	Formaldehyde (Formol)FDA Link 10/2016
1	ParaffinIBA 10/2016
1	Glucagon-Like Peptide 1 (GLP 1)IBA 05/2016
1	HDL cholesteryl esterIBA 02/2016
1	Cholesterol Esters (Cholesteryl Esters)IBA 02/2016
1	Cholesterol Ester Transfer ProteinsIBA 02/2016

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2019 - 11/2014
3	Bariatric Surgery 05/2016 - 02/2013
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2022 - 01/2018
2	Therapeutics 01/2021 - 07/2008
1	Critical Care (Surgical Intensive Care) 12/2021
1	Liver Transplantation 02/2019
1	Endovascular Procedures 01/2019
1	Immunotherapy 12/2017
1	Artificial Respiration (Mechanical Ventilation) 01/2017